Mutant Cell Repository, Camden, N J: PGF(GM3107), HLA-A3,A3; B7,B7; DR2,DR2; MB1; MT1; Te21; and MSTI(GM3161), HLA-A3,A3; B7,BT; DR2,DR2; MB1; MT1; Te21. The cell line Swei, HLA-A29,A29; B40,B40; DR5,DR5; MB3; MT2, MT4; Te22, was obtained from Dr. John Hansen. The cell line BK types as HLA-A2, A-unidentified; B49,B51; DR 1 ,DR5; MB1,MB3; MT1,MT2,MT4. The cell line MAR types as HLA-A2,A3; B18,B45; DR2,DR4; MB 1,MB3; MT1,MT3. The cells were maintained as previously described (4) .
Preparation of Radiolabeled Antigens. Class II antigens were radiolabeled with 35S-methionine (700-1300 Ci/mM, Amersham, Arlington Heights, IL) and immunoprecipitated with ailoantisera as previously reported (4) . Antisera. A summary of the serologically and immunochemically detected specificities of the alloantisera, defined as previously described (4), can be found in Table I .
Two-dimensional (2-D) Gel Electrophoresis. 2-D gel electrophoresis was performed according
to the method of O'Farrell (5) with some modifications as previously described (4) . The first dimension separation by isoelectric focusing (IEF) was performed in 5 × 200-mm cylindrical gels, after which the IEF gels were cut into two pieces that contained the a and ~8 chains, respectively. Each piece was applied to a separate sodium dodecyl sulfate-polyacrylamide slab gel.
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Results

2-D Gel Electrophoresis.
A ~S-methionine-labeled antigen preparation of the DR I,DR5 heterozygous cell line, BK, was immunoprecipiated with serum DA6, which had been absorbed with DR3 and DR4 cells (absorbed DA6), serum Ia-172, and serum MGH88B; the precipitated material was analyzed by 2-D gels. The fl chain portions of these gels are shown in Fig. I . The fl chain patterns of DA6 and Ia-172 consist of a heterogeneous set of nine spots as previously reported (4) . The fl chain pattern of MGH88B consists of at least four spots (a fifth more basic spot is occasionally seen) which are a subset of the DA6 and Ia-172 fl patterns. Based on these fl chain patterns, we have previously reported the existence of at least two structurally distinct fl chains on DR5 cells; one chain (previously referred to as L2) consisted of the four spots precipitated by MGH88B, whereas the other fl chain (previously referred to as L1) appeared to consist of the spots precipitated by DA6 and Ia-172, but not by MGH88B (4). However, {he fl pattern precipitated by the absorbed DA6 serum reveals the absence of two of the more basic spots precipitated by DA6 and Ia-172, but not by MGH88B. This result indicates that the portion of the fl chain pattern that is unique to DA6 and Ia-172 actually consists of two structurally distinct fl chains. To establish a basis for uniform nomenclature, we will designate the three fl chains ill, f12, and fin based on the isoelectric point (pI) of the most acidic spot in each fl chain. The fl chain whose most acidic spot is most acidic relative to the most acidic spots of the other two fl chains will be designated ill, whereas the fl chain whose most acidic spot is relatively most basic will be designated fla. The fl chain whose most acidic spot has a pI intermediate between the most acidic spots of fll and fla will be designated f12. Therefore, the fl chain precipitated only by MGH88B is fll (hatched spots), the fl chain precipitated by absorbed DA6, but not by MGH88B, is f12 (open spots), and the fl chain precipitated by DA6 and Ia-172, but not precipitated by absorbed DA6 or MGH88B is fla (closed spots). There is some molecular weight heterogeneity among the three fl chains; the spots of fix have a slightly lower molecular weight than the spots of f12. The most basic spot of fla has the same pI as the most basic spot of ill; however, the two spots are separable because of a very slight difference in molecular weights. The most acidic spot of fla has the same molecular weight as the most basic spot of f12; however, the two spots are separable because of a very slight difference in pI. Examination of the intervals between the spots that Fro. 1. Fluorographs of 2-D gels of fl chains precipitated from a aSS-methionine-labeled antigen preparation of the BK cell line (DR 1,DR5) by sera DA6, absorbed DA6, Ia-172, and MGH88B are shown at the left. Schematic representations of the spots in each gel are shown at the right. Schematic representations of the spots that comprise ill, fl2, and fls are shown at the bottom. Arrows indicate the two spots offls, which are precipitated by sera DA6 and Ia-172, but not by the absorbed DA6 serum. The two dark spots with <25,000 mol wt at the acidic end of some fl chain gels are an inconsistent finding and therefore do not appear to be related to the B chain spots. The row of spots at 44,000 daltons with MGH88B most likely represents HLA class I molecules. comprise each fl chain provides additional confirmation that the spots of each fl chain are more closely related to each other than to the spots of another fl chain. The spots of each distinct fl chain are separated from each other by some integral multiple of the shortest interval between two spots of that fl chain. For example, the interval between the middle spot offl2 and the most acidic spot offl2 is the same as the interval between the middle spot and the most basic spot. The shortest interval, or charge unit, is unique for each of the three fl chains.
In summary, serum MGH88B precipitated only ill. The fl chain pattern of absorbed DA6 contains fll and f12 and the/3 chain patterns of unabsorbed DA6 and Ia-172 include /3a, f12, and fla. These relationships are depicted schematically in Fig. 1 . Identical /3 chain patterns were observed when these sera were used to isolate Ia molecules from an antigen preparation of the DR5 homozygous cell line, Swei. The a chain patterns precipitated from DR5 antigen preparations by serum DA6 and serum Ia-172 (4) and by the absorbed DA6 serum (unpublished observations) consist of both al and as (previously referred to as H1 and H2, respectively), whereas the a chain pattern of serum MGH88B consists only of a2 (4) .
To determine whether the demonstration of a third human Ia/3 chain could be generalized, a ~S-methionine-labeled antigen preparation of the DR2 homozygous cell line, MST1, was immunoprecipitated with sera Dobbe, Banaszak, MGH72, and Pohl; the precipitated material was then compared by 2-D gels (Fig. 2) . Serum Banaszak precipitated a complex fl chain pattern of eleven spots. Serum Dobbe precipitated only eight of the same spots precipitated by Banaszak, whereas Pohl precipitated a more restricted subset of the Banaszak/3 pattern. MGH72 precipitated a pattern that was qualitatively the same as the Dobbe pattern. These complex/3 chain patterns can be explained by postulating no fewer than three structurally distinct/3 chains, which we have labeled fix, /32, and/3s using the same criteria as described above./31 (five hatched spots) is precipitated by all four sera; however, Pohl isolates /31 alone. /32 (three open spots) is precipitated by Dobbe, Banaszak, and MGH72, but not by Pohl./3s is precipitated only by Banaszak. Compared with the three/3 chains from DR5 cells, there is less molecular weight heterogenity among the three/3 chains from DR2 cells.
According to this construct, the complex/3 chain pattern precipitated by Banaszak includes/31,/32, and/33. The Dobbe/3 chain pattern contains/3x and/32, but lacks/3s. Quantitatively similar amounts of/31 are precipitated by both Dobbe and Banaszak; however, Dobbe precipitated more/32 than Banaszak. Serum Ia-715 precipitated a/3 chain pattern identical to Dobbe (data not shown). Serum MGH72 precipitated primarily/32, but also a small amount of/31. Serum Pohl precipitated only fla. These relationships are depicted schematically in Fig. 2 . Again, examination of the intervals between the spots that comprise each/3 chain confirms that the spots of each/3 chain are more closely related to each other than to the spots of the other/3 chains; the shortest interval is unique for each of the three/3 chains. Identical/3 chain patterns were observed when these sera were used to isolate Ia molecules from antigen preparations of another DR2 homozygous cell line, PGF, and a DR2 heterozygous cell line, MAR (data not shown). The a chain patterns precipitated by Banaszak, Dobbe, MGH72, and Pohl consisted of al and variable amounts of a2 (data not shown)
Discussion
The data presented here document for the first time the existence of a third structurally distinct human Ia fl chain. The use of alloantisera, which contain antibodies to polymorphic determinants on Ia molecules, provided a significant advantage in these studies because we were able to investigate the same antigens on both DR heterozygous and homozygous cell lines. In contrast, most anti-Ia monoclonal antibodies recognize monomorphic determinants and, therefore, cannot be used to isolate individual Ia molecules from DR heterozygous cell lines.
The complex array of fl chain patterns precipitated from two HLA-DR2 homozygous cell lines and one HLA-DR2 heterozygous cell line by four alloantisera can be explained by the existence of no fewer than three structurally distinct fl chains, termed fix, f12, and fla. The two spots of fla were precipitated only by serum Banaszak. The existence of a third fl chain was also demonstrated on both HLA-DR5 homozygous and heterozygous cell lines when two spots that were precipitated by serum DA6 and serum Ia-172 were not precipitated by the absorbed DA6 serum. The demonstration that identical ill, f12, and fls patterns are precipitated from DR5 homozygous and DR1, DR5 heterozygous cell lines, coupled with the observation that the DR1-associated fl chains are distinct from the DR5-associated fl chains (data not shown) excludes the possibility that the third fl chain is due to the lack of true HLA-DR homozygosity. The designations, fix, f12 and fin of fl chains isolated from DR2 and DR5 cells were assigned solely based on the pI of the most acidic spot of each fl chain; the data presented here do not allow any conclusions about possible homology between, for example, the DR2 fll and the DR5 fla. There appears to be structural polymorphism of all three fl chains since none of the three fl chains from DR2 cells are structurally identical to any of the three fl chains from DR5 cells.
Several studies using both alloantisera and monoclonal antibodies have recently established the presence of two a chains and two fl chains that combined to form two class II molecules on HLA-DR homozygous cells (1-4). Shackelford et al. (1) also used alloantisera and 2-D gels to investigate the Ia molecules expressed by the DR2 homozygous cell line, PGF. They found a total of 10 fl chain spots using a combination of sera. A DR2 alloantiserum precipitated a fl chain pattern consisting of seven spots. They postulated, but did not demonstrate, that this pattern might represent two fl chains. Sera for the specificities MB 1, MT 1, DC 1, and LB 12, including serum Ia-715, which was used in the present study, precipitated a fl chain pattern of three spots that were distinct from the spots precipitated by the DR2 serum. Although we have detected a similar total number of fl chain spots from DR2 antigen preparations, we found that three anti-MB1/MT1 sera (Dobbe, Ia-715, and MGH72) precipitated, with some quantitative variation, a fl chain pattern consisting of seven spots (ill and f12). The reason for the differences between our results and those of Shackelford, et al.
(1) are unclear, but these observations suggest that there may be considerable heterogeneity among sera that define the same serologic specificity.
An impressive degree of homology has been found between the Ia molecules determined by the murine and human MHC. Until recently, only two a chains, A~ and E~, and two fl chains, A~ and EO, have been thought to comprise the murine I-A and I-E molecules. However, two studies have suggested that there may be two structurally distinct I-E molecules (and, therefore, presumably three Ia fl chains) in some haplotypes (6, 7) . Human Ia molecules that appear to be equivalent to the murine I-A and I-E molecules based on amino acid sequence homology have recently been isolated with monoclonal antibodies (3) . Additional studies are now in progress to determine which of the three human Ia fl chains we have identified with allosera correspond to these human I-A or I-E equivalent molecules.
Previous data (1-4) from several groups have documented that at least two structurally distinct Ia a and Ia fl chains are expressed on HLA-DR homozygous cell lines, whereas a more recent study (8) postulated the existence of at least seven Ia fl chains based on partial amino acid sequence data. The data presented in this report demonstrate the existence of a third human Ia fl chain. This suggests that at least five separate genes control the expression of class II molecules on HLA-DR homozygous cell lines.
Summary
Previous studies have indicated that HLA-DR homozygous cell lines express two Ia a and Ia fl chains that combine to form at least two Ia molecules. This report demonstrates by two-dimensional gel electrophoresis the existence of a third structurally distinct human Ia fl chain on DR2 and DR5 cell lines. This suggests that at least five separate genes control the expression of Ia molecules on HLA-DR homozygous cell lines.
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